The National Cancer Act of 1971 officially started what is commonly referred to as the "War on Cancer."
During his State of the Union in January 1971, President Richard Nixon said: " I will ... ask for an appropriation of an extra U.S. $100 million to launch an intensive campaign to find a cure for cancer, and I will ask later for whatever additional funds can effectively be used. The time has come in America when the same kind of concentrated effort that split the atom and took a man to the moon should be turned toward conquering this dread disease. Let us make a total national commitment to achieve this goal..."
The act, signed into law by President Richard Nixon on Friday, December 23, 1971, was an amendment to the Public Health Service Act of 1944 and represented the U.S. commitment to eradicating cancer, a disease which had, in 1970, become the nation's second leading cause of death.
Since the signing of the bill, billions of dollars have been used towards "a total national commitment towards the conquest of cancer" with the stated goal of "finding a cure."
Government spending has been tremendously beneficial, providing funding for basic cancer research which is the foundation for new cancer treatment. As a result of ongoing research we now have a tremendous wealth of information, a better understanding of cancer biology and many novel treatments.
But there is still a lot of work ahead of us.
Although considerable progress has indeed been made in the treatment of some cancers, treatment of others remains elusive. A definite cure for cancer has not yet been found...
In this first edition of "Changing Strategies in the War on Cancer" (Early Diagnosis - The New Paradigm), Amit Kumar, Ph.D., Chairman, President & Chief Executive Officer of Anixa Biosciences, the inventor of our Cchek™ technology, discussing the importance and the impact of early diagnosis.
© 2016 Sunvalley Communication, LLC
This episode is sponsored by
Anixa Biosciences, Inc.
3150 Almaden Expressway
San Jose, CA 95118